Laparoscopic and robotic postchemotherapy retroperitoneal lymph node dissection.
OBJECTIVE
Open surgical postchemotherapy retroperitoneal lymph node dissection remains the standard of care. On the contrary, laparoscopy is an emerging technique and reports of laparoscopic lymph node dissection postchemotherapy are increasing. Our purpose is to present indications, technique and outcomes of laparoscopic postchemo retroperitoneal lymph node dissection.


RESULTS
With growing expertise and knowledge the morbidity of the laparoscopic approach is much reduced compared with open surgery with the same oncological outcome. Robotic surgery is a more recent approach with growing usage in urology. However, no reports of robotic postchemotherapy lymph node dissection are available.


CONCLUSIONS
In expert hands laparoscopic lymph node dissection is a feasible technique, offering less morbidity to patients with good oncological results.
Department of Urology and Andrology, Paracelsus Medical University Salzburg, Salzburg, Austria.
Thomas
T
Kunit
Günter
G
Janetschek
D017024:Chemotherapy, Adjuvant; D006801:Humans; D010535:Laparoscopy / Q000009:adverse effects; D008197:Lymph Node Excision / Q000009:adverse effects / Q000379:methods*; D008207:Lymphatic Metastasis; D008297:Male; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000556:secondary / Q000628:therapy*; D012187:Retroperitoneal Space; D012371:Robotics; D025321:Surgery, Computer-Assisted / Q000009:adverse effects; D013736:Testicular Neoplasms / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome